AI assistant
CVS HEALTH Corp — Director's Dealing 2012
Jul 3, 2012
29875_dirs_2012-07-03_3cf24168-6c12-4135-836a-681d4f42ef16.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-07-02
Reporting Person: MERLO LARRY J (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-02 | Common Stock | M | 80679 | $30.035 | Acquired | 228059.5269 | Direct |
| 2012-07-02 | Common Stock | S | 80679 | $46.95 | Disposed | 147380.5269 | Direct |
| 2012-07-02 | Common Stock | M | 80680 | $30.035 | Acquired | 228060.5269 | Direct |
| 2012-07-02 | Common Stock | S | 80680 | $46.96 | Disposed | 147380.5269 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-07-02 | Stock Option | $30.035 | M | 80679 | Disposed | 2013-04-03 | Common Stock (80679) | Direct |
| 2012-07-02 | Stock Option | $30.035 | M | 80680 | Disposed | 2013-04-03 | Common Stock (80680) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 333126.6339 | Indirect |
| Common Stock (restricted) | 288004 | Direct |
| ESOP Common Stock | 6239.5451 | Indirect |
| Stock Unit | 278877.9157 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Credits | $1.00 | Common Stock (5205.5266) | 5205.5266 | Direct | |
| Stock Option | $34.42 | 2014-04-02 | Common Stock (136089) | 136089 | Direct |
| Stock Option | $41.17 | 2015-04-01 | Common Stock (144144) | 144144 | Direct |
| Stock Option | $28.10 | 2016-04-01 | Common Stock (185572) | 185572 | Direct |
| Stock Option | $36.23 | 2017-04-01 | Common Stock (152988) | 152988 | Direct |
| Stock Option | $34.96 | 2018-04-01 | Common Stock (241150) | 241150 | Direct |
| Stock Option | $45.07 | 2019-04-02 | Common Stock (332736) | 332736 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $46.76 and $47.03 per share.
F3: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging from $46.74 and $47.03 per share.
F4: Option became exercisable in three equal annual installments, commencing 4/3/2007.
F5: Each share credit is equivalent to one share; 1-for-1 conversion.
F6: Reflects 2002 and 2003 year end company match share credits of 33 and 27, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F7: Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such timee as has been elected by the reporting person.
F8: Option became exercisable in three equal annual installments, commencing 4/2/2008.
F9: Option became exercisable in three equal annual installments, commencing 4/1/2009.
F10: Option became exercisable in three equal annual installments, commencing 4/1/2010.
F11: Option became exercisable in three equal annual installments, commencing 4/1/2011.
F12: Option became exercisable in four equal annual installments, commencing 4/1/2012.
F13: Option becomes exercisable in four equal annual installments, commencing 4/2/2013.